Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood.
about
Lysosomal storage disease: gene therapy on both sides of the blood-brain barrier.A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB.Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB.Adeno-Associated Virus-Based Gene Therapy for CNS Diseases.Near-Complete Correction of Profound Metabolomic Impairments Corresponding to Functional Benefit in MPS IIIB Mice after IV rAAV9-hNAGLU Gene Delivery.Broad functional correction of molecular impairments by systemic delivery of scAAVrh74-hSGSH gene delivery in MPS IIIA mice.Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy.Blood genome-wide transcriptional profiles reflect broad molecular impairments and strong blood-brain links in Alzheimer's disease.Evaluation of enzyme dose and dose-frequency in ameliorating substrate accumulation in MPS IIIA Huntaway dog brain.
P2860
Q35034401-B2ED996F-50A0-453F-892E-0EECD7539EBDQ36521756-CA4A9E06-F36B-4A6A-ADA8-C6E148A87F03Q38851110-89C5BECA-0735-4FAF-A9D6-11359B882032Q38856794-248E649C-61DA-4510-B735-76E9040EF521Q38988296-73EB0AD3-0A19-4B65-ADB8-E3B5A97F615AQ39600788-E915846F-9379-4894-BC6B-D75B87D344D5Q42176546-DB82DA7B-DFCD-4839-AE75-44CB896DAFACQ45867306-1CDD7465-138C-42A5-BE86-F300ED0D6114Q48448348-C6387658-D4A6-4121-B0C8-5AC3B9D9887E
P2860
Amyloidosis, synucleinopathy, and prion encephalopathy in a neuropathic lysosomal storage disease: the CNS-biomarker potential of peripheral blood.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@ast
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@en
type
label
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@ast
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@en
prefLabel
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@ast
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@en
P2093
P2860
P1433
P1476
Amyloidosis, synucleinopathy, ...... potential of peripheral blood.
@en
P2093
Aaron Meadows
Bartholomew J Naughton
Darren Murrey
Douglas M McCarty
F Jason Duncan
Tierra Ware
P2860
P304
P356
10.1371/JOURNAL.PONE.0080142
P407
P577
2013-11-21T00:00:00Z